Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Translational Lung Cancer Research
|
December 15, 2022
ADK-VR2, a cell line derived from a treatment-naïve patient with <i>SDC4-ROS1</i> fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC
Francesca Ruzzi, Stefania Angelicola, Lorena Landuzzi, et al.
Cancer Research
|
December 14, 2021
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
Marianna Carrabotta, Maria Antonella Laginestra, Giorgio Durante, et al.
Breast Cancer Research : BCR
|
January 24, 2014
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2
Carla De Giovanni, Giordano Nicoletti, Elena Quaglino, et al.
Biomedicines
|
October 27, 2022
Prevention and Therapy of Metastatic HER-2<sup>+</sup> Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine
Francesca Ruzzi, Arianna Palladini, Stine Clemmensen, et al.
Scientific Reports
|
August 23, 2019
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
Patrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, et al.
Oncotarget
|
September 15, 2017
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response
Arianna Palladini, Giordano Nicoletti, Alessia Lamolinara, et al.
Oncoimmunology
|
February 6, 2018
Virus-like particle display of HER2 induces potent anti-cancer responses
Arianna Palladini, Susan Thrane, Christoph M Janitzek, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 7, 2025
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma
Maria Cristina Manara, Francesca Bruzzese, Laura Formentini, et al.
Scientific Reports
|
January 16, 2021
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft
Lorena Landuzzi, Arianna Palladini, Claudio Ceccarelli, et al.
The International Journal of Biological Markers
|
September 30, 2009
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis
Angelo Paradiso, Anita Mangia, Claudio Orlando, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Translational Lung Cancer Research
|
December 15, 2022
ADK-VR2, a cell line derived from a treatment-naïve patient with <i>SDC4-ROS1</i> fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC
Francesca Ruzzi, Stefania Angelicola, Lorena Landuzzi, et al.
Cancer Research
|
December 14, 2021
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
Marianna Carrabotta, Maria Antonella Laginestra, Giorgio Durante, et al.
Breast Cancer Research : BCR
|
January 24, 2014
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2
Carla De Giovanni, Giordano Nicoletti, Elena Quaglino, et al.
Biomedicines
|
October 27, 2022
Prevention and Therapy of Metastatic HER-2<sup>+</sup> Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine
Francesca Ruzzi, Arianna Palladini, Stine Clemmensen, et al.
Scientific Reports
|
August 23, 2019
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
Patrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, et al.
Oncotarget
|
September 15, 2017
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response
Arianna Palladini, Giordano Nicoletti, Alessia Lamolinara, et al.
Oncoimmunology
|
February 6, 2018
Virus-like particle display of HER2 induces potent anti-cancer responses
Arianna Palladini, Susan Thrane, Christoph M Janitzek, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 7, 2025
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma
Maria Cristina Manara, Francesca Bruzzese, Laura Formentini, et al.
Scientific Reports
|
January 16, 2021
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft
Lorena Landuzzi, Arianna Palladini, Claudio Ceccarelli, et al.
The International Journal of Biological Markers
|
September 30, 2009
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis
Angelo Paradiso, Anita Mangia, Claudio Orlando, et al.
Page
of 9